DM

Showing posts with label Examines. Show all posts
Showing posts with label Examines. Show all posts

Wednesday, August 7, 2013

New online course examines mouse as a model for prostate cancer

Davis, CA (press BOX) 10 July 2013

Coming soon! UC Davis extension landmark online series, Pathobiology of the mouse which has received several national awards in the past three years, will add a new course this year - mouse as a model for prostate cancer. Dr. Robert D. Cardiff, m.d., Ph.d., UC Davis Distinguished Professor Emeritus and employees continue to developed skills through their content and detailed to facilitate online discussion.

The Pathobiology of which mouse program consists of two levels: I, technicians, and all level work with GEM and level II for enrolled students and doctors, designed, M.D.s. mouse as a model for prostate cancer is the second place in stage II.

Summer and fall courses are listed, to register with http://extension.ucdavis.edu:

Stage IA, Pathobiology of the mouse: Register now through September 27 students have 15 weeks to complete the course. $1,250 Tuition /$ 1,000 for students.

Stage IB, Pathobiology of the mouse: You sign up now through September 27 $1,350 tuition /$ 1,080 for students.

Level II, mouse as a model for the mammary gland cancer: Register 27 $2,295 tuition/1,836 for PhD students now through September

Other courses in development for level II include toxicological pathology, leukemia, lymphoma, and much more.

Mouse Pathobiology training modules are now available. These short, self-taught modules created by content in the landmark Pathobiology of the mouse, stages IA and IB, and between 3-8 take hours to complete. These modules may be taken to fulfill continuing medical education credits.

Information on discounts for groups of three or more, or licensing opportunities please contact Howard Mahoney (530-757-8512; hsmahoney(at)ucdavis(dot)edu)

A free online information event is available at http://extensiondlc.net/infosite/GNP100/player.html.

A free video explains the program is available at http://youtube.com/watch?v=QgoPOybUFFc.

Close the genomic revolution and today to register!

Accreditation
This activity is planned and implemented in accordance with the essential areas and policies of the Accreditation Council for continuing medical education (ACCME) through the joint promotion of the extension was University of California, Davis health system and the UC Davis. The University of California, Davis health system is accredited by the ACCME to medical training for doctors.

Doctor loan
The University of California, Davis health system designates this live activity for maximum 12 AMA PRA category 1 credits ?. physicians should make only credit according to assert the extent of their participation in the activity.



View the original article here

Wednesday, July 10, 2013

Study Examines Spiritual Support For Patients With Advanced Cancer

Main Category: Cancer / Oncology
Article Date: 08 May 2013 - 2:00 PDT Current ratings for:
Study Examines Spiritual Support For Patients With Advanced Cancer
not yet ratednot yet rated
JAMA Internal Medicine Study Highlights

A study by Tracy A. Balboni, M.D., M.P.H., of the Dana-Farber Cancer Institute, Boston, and colleagues suggests that spiritual care and end-of-life (EoL) discussions by the medical team may be associated with reduced aggressive treatment.

The study included 343 patients with advanced cancer. EoL care in the final week included hospice, aggressive EoL measures (care in an intensive care unit, resuscitation or ventilation), and ICU death.

Patients reporting high spiritual support from religious communities were less likely to receive hospice (adjusted odds ratio [AOR], 0.37), more likely to receive aggressive EoL measures (AOR, 2.62), and more likely to die in an ICU (AOR, 5.22), according to the results. The results also indicate that among patients well-supported by religious communities, receiving spiritual support from the medical team was associated with higher rates of hospice use (AOR, 2.37), fewer aggressive treatments ((AOR, 0.23), fewer ICU deaths (AOR, 0.19) and EoL discussions were associated with fewer aggressive interventions (AOR, 0.12).

"In conclusion, terminally ill patients receiving high spiritual support from religious communities receive more-intensive EoL medical care, including less hospice, more aggressive interventions, and more ICU deaths, particularly among racial/ethnic minority and high religious coping patients," the study concludes. "The provision of spiritual care and EoL discussions by medical teams to patients highly supported by religious communities is associated with reduced medical care intensity near death."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject. JAMA Internal Med. Published online May 6, 2013. doi:10.1001/jamainternmed.2013.903. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Medicine, JAMA Internal. "Study Examines Spiritual Support For Patients With Advanced Cancer." Medical News Today. MediLexicon, Intl., 8 May. 2013. Web.
13 May. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Study Examines Spiritual Support For Patients With Advanced Cancer'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Monday, May 27, 2013

Study Examines Use Of Creative Arts Therapies Among Patients With Cancer

Main Category: Cancer / Oncology
Also Included In: Depression;??Anxiety / Stress
Article Date: 13 May 2013 - 13:00 PDT Current ratings for:
Study Examines Use Of Creative Arts Therapies Among Patients With Cancer
not yet ratednot yet rated
JAMA Internal Medicine Study Highlights

Creative arts therapies (CATs) can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues.

Authors reviewed the available medical literature and included 27 studies involving 1,576 patients. Researchers found that during treatment, CAT significantly reduced anxiety, depression and pain, and increased quality of life. However, the effects were greatly diminished during follow-up, the study concludes.

"Future well-designed RCTs are needed to address the methodological heterogeneity found within this field of research," according to the study.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cancer / oncology section for the latest news on this subject. JAMA Internal Med. Published online May 13, 2013. doi:10.1001/jamainternmed.2013.836. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Medicine, JAMA Internal. "Study Examines Use Of Creative Arts Therapies Among Patients With Cancer." Medical News Today. MediLexicon, Intl., 13 May. 2013. Web.
20 May. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Study Examines Use Of Creative Arts Therapies Among Patients With Cancer'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here